History of Liver Transplantation
From impossible dream to routine life-saving surgery — the remarkable 60-year journey that turned liver failure from a death sentence into a treatable condition. This page traces the pioneers, breakthroughs, and milestones that made today’s transplants possible.
Early Experiments (1950s–1960s)
In 1955, Jack Cannon performed the first animal liver transplant. By 1963, Thomas Starzl’s team had perfected canine techniques and was ready for humans. These dog experiments proved the liver could be removed and replaced — but rejection and bleeding remained insurmountable. Survival was measured in hours or days.[1]
Starzl’s First Human Transplants (1963–1967)
March 1, 1963: Starzl performed the world’s first human liver transplant on a 3-year-old with biliary atresia — the child died intraoperatively. Five more attempts in 1963 all failed quickly. In 1967, the first long-term survivor lived 13 months. These cases established surgical feasibility despite universal early rejection.[1]
Cyclosporine Revolution (1979–1983)
Roy Calne introduced cyclosporine in 1979 — a fungus-derived immunosuppressant. One-year survival leapt from ~20% to over 70%. In 1983, a U.S. National Institutes of Health consensus declared liver transplantation a clinical therapy, not experimental. Cyclosporine made transplantation viable worldwide.[1]
Survival Milestones (1980s–1990s)
1980s: First successful pediatric programs (Starzl, Pittsburgh). 1990s: Tacrolimus proved superior to cyclosporine. Split-liver and living-donor techniques emerged. By 1995, one-year survival exceeded 85%. The MELD score (2002) reduced waitlist deaths by 15% and made allocation evidence-based.[1]
21st Century Advances
Machine perfusion extended organ viability. Direct-acting antivirals cured hepatitis C post-transplant. Normothermic regional perfusion and expanded-criteria donors increased utilization. By 2024, 5-year survival exceeds 80%, with many patients living 20–30+ years in excellent health — unimaginable in 1963.[1]
Today & Tomorrow
Over 10,000 liver transplants occur annually worldwide. Challenges remain: organ shortage and geographic inequity. Future frontiers: xenotransplantation (genetically modified pig livers), bioengineered organs, tolerance induction (no immunosuppression), and regenerative therapies. What began as a daring experiment is now one of medicine’s greatest triumphs.[1]